In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs

Veterinary Dermatology

Volumn 23, Issue 6, 2012, Pages

  Valentine, Becky K ^a   Dew, Walter ^a   Yu, Anthony ^a   Weese, J Scott ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; DOG; DOG DISEASE; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; DOG DISEASES; DOGS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; CITRUS X PARADISI; MELALEUCA ALTERNIFOLIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 84869093047     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01095.x     Document Type: Article

References (33)

1. Escher M, Vanni M, Intorre L et al. Use of antimicrobials in companion animal practice: a retrospective study in a veterinary teaching hospital in Italy. J Antimicrob Chemother 2011; 66: 920-927.
2. Thomson KH, Rantala MHJ, Viita-Aho TK et al. Condition-based use of antimicrobials in cats in Finland: results from two surveys. J Feline Med Surg 2009; 11: 462-466.
3. Fitzgerald JR. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance. Vet Dermatol 2009; 20: 490-495.
4. Fulham KS, Lemarie SL, Hosgood G et al. In vitro susceptibility testing of meticillin-resistant and meticillin-susceptible staphylococci to mupirocin and novobiocin. Vet Dermatol 2011; 22: 88-94.
5. Nienhoff U, Kadlec K, Chaberny IF et al. Meticillin-resistant Staphylococcus pseudintermedius among dogs admitted to a small animal hospital. Vet Microbiol 2011; 150: 191-197.
6. Norström M, Sunde M, Tharaldsen H et al. Antimicrobial resistance in Staphylococcus pseudintermedius in the Norwegian dog population. Microb Drug Resist 2009; 15: 55-59.
7. Loeffler A, Linek M, Moodley A et al. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet Dermatol 2007; 18: 412-421.
8. Morris DO, Boston RC, O'Shea K et al. The prevalence of carriage of meticillin-resistant staphylococci by veterinary dermatology practice staff and their respective pets. Vet Dermatol 2010; 21: 400-407.
9. Rusher C, Lübke-Becker A, Semmler T et al. Widespread rapid emergence of a distinct meticillin- and multidrug-resistant Staphylococcus pseudintermedius (MRSP) genetic lineage in Europe. Vet Microbiol 2010; 144: 340-346.
10. Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 1999; 86: 985-990.
11. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48: 5-16.
12. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement. NCCLS document M100-S14, volume 24, no. 1. Wayne, PA: NCCLS, 2004.
13. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Fusidic acid; Rationale for the EUCAST clinical breakpoints version 1.0. 2010 Available at: http://www.EUCAST.org. Accessed June 25, 2012.
14. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Mupirocin; Rationale for the EUCAST clinical breakpoints version 1.0. 2010 Available at: http://www.EUCAST.org Accessed June 25, 2012.
15. Manson JM, Smith JMB, Cook GM. Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use. Appl Environ Microbiol 2004; 70: 5764-5768.
16. Loeffler A, Cobb MA, Bond R. Comparison of a chlorhexidine and a benzoyl peroxide shampoo as a sole treatment in canine superficial pyoderma. Vet Rec 2011; 169: 249-254.
17. Murayama N, Nagata M, Terada Y et al. Efficacy of a surgical scrub including 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol 2010; 21: 586-592.
18. Murayama N, Terada Y, Okuaki M et al. Dose assessment of 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol 2011; 22: 449-453.
19. Seltzer JD, Flynn-Lurie AK, Marsella R et al. Investigation of the clinical efficacy of 0.2% topical stannous fluoride for the treatment of canine superficial pyoderma: a prospective, randomized, double-blinded, placebo-controlled trial. Vet Dermatol 2010; 21: 249-258.
20. Sheng WH, Wang JT, Lauderdale TL et al. Epidemiology and susceptibilities of meticillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility. Diagn Microbiol Infect Dis 2009; 63: 309-313.
21. Akimitsu N, Hamamoto H, Inoue R et al. Increase in resistance of meticillin-resistant Staphylococcus aureus to β-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999; 43: 3042-3043.
22. Al-Masaudi SB, Day MJ, Russell AD. Sensitivity of meticillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics, and disinfectants. J Appl Bacteriol 1988; 65: 329-337.
23. Liu Q, Liu M, Wu Q et al. Sensitivities to biocides and distribution of biocide resistance genes in quaternary ammonium compound tolerant Staphylococcus aureus isolated in a teaching hospital. Scand J Infect Dis 2009; 41: 403-409.
24. Cottell A, Denyer SP, Hanlon GW et al. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics. J Hosp Infect 2009; 72: 71-76.
25. Edwards-Jones V, Buck R, Shawcross SG et al. The effect of essential oils on meticillin-resistant Staphylococcus aureus using a dressing model. Burns 2004; 30: 772-777.
26. Brady A, Loughlin R, Gilpin D et al. In vitro activity of tea-tree oil against clinical skin isolates of meticillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J Med Microbiol 2006; 55: 1375-1380.
27. Carson CF, Cookson BD, Farrelly HD et al. Susceptibility of meticillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 1995; 35: 421-424.
28. O'Neill AJ, Larsen AR, Henrikson AS et al. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother 2004; 48: 3594-3597.
29. Loeffler A, Baines SJ, Toleman MS et al. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. J Antimicrob Chemother 2008; 62: 1301-1304.
30. Nagaev I, Björkman J, Anderson DI et al. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001; 40: 433-439.
31. Afset JE, Maeland JA. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus. Scand J Infect Dis 2003; 35: 84-89.
32. Carson CF, Riley TV, Cookson BD. Efficacy and safety of tea tree oil as a topical antimicrobial agent. J Hosp Infect 1998; 40: 175-178.
33. Faoagali J, George N, Leditschke JF. Does tea tree oil have a place in the topical treatment of burns?Burns 1997; 23: 349-351.